Recurrent vulvovaginal candidiasis

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 1, 2016, Pages 15-21

  Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antifungals; antimycotics; Candida vaginitis; vaginal candidosis; vulvovaginal candidiasis

Indexed keywords

CANDIDA ALBICANS VACCINE; FLUCONAZOLE; PROBIOTIC AGENT; ANTIFUNGAL AGENT;

CANDIDA ALBICANS; CLINICAL FEATURE; FEMALE; GENETIC SUSCEPTIBILITY; HEREDITY; HORMONE SUBSTITUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MAINTENANCE THERAPY; MENOPAUSE; MORBIDITY; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SPECIES IDENTIFICATION; VAGINA CANDIDIASIS; VAGINA FLORA; VAGINA PH; ANTIFUNGAL RESISTANCE; CANDIDIASIS, VULVOVAGINAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; DRUG RESISTANCE, FUNGAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROBIOTICS; RECURRENCE;

EID: 84955654419     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.06.067     Document Type: Review

References (64)

1. J.D. Sobel Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis Am J Obstet Gynecol 152 1985 924
2. E. Hong, S. Dixit, P.L. Fidel, J. Bradford, and G. Fischer Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition J Low Genit Tract Dis 18 2014 31 38
3. J.D. Sobel, S. Faro, R.W. Force, and et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations Am J Obstet Gynecol 178 1998 203 211
4. J.D. Sobel Vulvovaginal candidosis Lancet 369 2007 1961 1971
5. S.D. Rathod, and P.A. Buffler Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented BMC Womens Health 14 2014 43 47
6. D.G. Ferris, P. Nyirjesy, J.D. Sobel, D. Soper, A. Pavletic, and M.S. Litaker Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis Obstet Gynecol 99 2002 419 425
7. B. Foxman, R. Barlow, H. D'Arcy, B. Gillespie, and J.D. Sobel Candida vaginitis: self-reported incidence and associated costs Sex Transm Dis 27 2000 230 235
8. B. Foxman, R. Muraglia, J.P. Dietz, J.D. Sobel, and J. Wagner Prevalence of recurrent vulvovaginal candidiasis In 5 European countries and the United States: results from an internet panel survey J Low Genit Tract Dis 17 2013 340 345
9. G. Fischer, and J. Bradford Vulvovaginal candidiasis in postmenopausal women: the role of hormone replacement therapy J Low Genit Tract Dis 15 2011 263 267
10. M. Ilkit, and A.B. Guzel The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective Crit Rev Microbiol 37 2011 250 261
11. J.D. Sobel Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy N Engl J Med 315 1986 1455 1458
12. J.D. Sobel, H.C. Wiesenfeld, M. Martens, and et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis N Engl J Med 351 2004 876 883
13. G. Donders, G. Bellen, G. Byttebier, and et al. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial) Am J Obstet Gynecol 199 2008 613 619
14. P. Nyirjesy, Y. Zhao, K. Ways, and K. Usiskin Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor Curr Med Res Opin 28 2012 1173 1178
15. M.A. Kennedy, and J.D. Sobel Vulvovaginal candidiasis caused by non-albicans Candida species: new insights Curr Infect Dis Rep 12 2010 465 470
16. G. Dennerstein Management of recurrent vaginitis Drugs 21 1981 231 235
17. H.R. Conti, A.C. Peterson, L. Brane, and et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections J Exp Med 211 2014 2075 2084
18. A. Gladiator, N. Wangler, K. Trautwein-Weidner, and S. LeibundGut-Landmann Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection J Immunol 190 2013 521 525
19. M.G. Netea, G.D. Brown, B.J. Kullberg, and N.A. Gow An integrated model of the recognition of Candida albicans by the innate immune system Nat Rev Microbiol 6 2008 67 78
20. A. De Luca, A. Carvalho, C. Cunha, and et al. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis PLoS Pathog 9 2013 e1003486
21. D. Pietrella, A. Rachini, M. Pines, and et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis PLoS One 6 2011 e22770
22. B. Ferwerda, G. Ferwerda, T.S. Plantinga, and et al. Human dectin-1 deficiency and mucocutaneous fungal infections N Engl J Med 361 2009 1760 1767
23. F.L. van de Veerdonk, T.S. Plantinga, A. Hoischen, and et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis N Engl J Med 365 2011 54 61
24. B. Usluogullari, I. Gumus, E. Gunduz, and et al. The role of human dectin-1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections Mol Biol Rep 41 2014 6763 6768
25. D.C. Rosentul, C.E. Delsing, M. Jaeger, and et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis Front Microbiol 5 2014 1 7
26. M. Ben-Ali, B. Corre, J. Manry, and et al. Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family Hum Mutat 32 2011 643 652
27. G.E. Etokebe, F. Skjeldal, N. Nilsen, and et al. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele Scand J Immunol 71 2010 369 381
28. L. Romani Immunity to fungal infections Nat Rev Immunol 11 2011 275 288
29. N.A. Gow, M.G. Netea, C.A. Munro, and et al. Immune recognition of Candida albicans beta-glucan by dectin-1 J Infect Dis 196 2007 1565 1571
30. O. Babula, G. Lazdane, J. Kroica, W.J. Ledger, and S.S. Witkin Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women Clin Infect Dis 37 2003 733 737
31. M. Wang, F. Wang, J. Yang, and et al. Mannan-binding lectin inhibits Candida albicans-induced cellular responses in PMA-activated THP-1 cells through Toll-like receptor 2 and Toll-like receptor 4 PLoS One 8 2013 e83517
32. O. Babula, G. Lazda¯ne, J. Kroica, I.M. Linhares, W.J. Ledger, and S.S. Witkin Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis Clin Infect Dis 40 2005 1258 1262
33. F. Liu, Q. Liao, and Z. Liu Mannose-binding lectin and vulvovaginal candidiasis Int J Gynaecol Obstet 92 2006 43 47
34. G.G. Donders, O. Babula, G. Bellen, I.M. Linhares, and S.S. Witkin Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis BJOG 115 2008 1225 1232
35. M.D. Wojitani, L.M. de Aguiar, E.C. Baracat, and I.M. Linhares Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis Arch Gynecol Obstet 285 2011 149 153
36. B. Nedovic, B. Posteraro, E. Leoncini, and et al. Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta-analysis Biomed Res Int 2014 2014 738298
37. M.R. Anderson, K. Klink, and A. Cohrssen Evaluation of vaginal complaints JAMA 291 2004 1368 1379
38. R. Hurley Inveterate vaginal thrush Practioners 215 1975 753
39. S. Aballéa, F. Guelfucci, J. Wagner, and et al. Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA Health Qual Life Outcomes 11 2013 169 175
40. C.M. Elie, T.J. Lott, E. Reiss, and C.J. Morrison Rapid identification of Candida species with species-specific DNA probes J Clin Microbiol 36 1998 3260 3265
41. N.K. Lowe, J.L. Neal, and N.A. Ryan-Wenger Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard Obstet Gynecol 113 2009 89 95
42. J.D. Sobel, and R.A. Akins The role of PCR in the diagnosis of Candida vulvovaginitis-a new gold standard? Curr Infect Dis Rep 17 2015 488
43. C.P. Cartwright, B.D. Lembke, K. Ramachandran, and et al. Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women J Clin Microbiol 51 2013 3694 3699
44. T. Weissenbacher, S.S. Witkin, W.J. Ledger, and et al. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction Arch Gynecol Obstet 279 2009 125 129
45. A. Spinillo, L. Colonna, G. Piazzi, F. Baltaro, A. Monaco, and A. Ferrari Managing recurrent vulvovaginal candidiasis: intermittent prevention with itraconazole J Reprod Med 42 1997 83 87
46. M.J. Balsdon, and J.M. Tobin Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment Genitourin Med 64 1988 124 127
47. A.C. Roth, I. ilsom, L. Forssman, and P. Wåhlén Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet Genitourin Med 66 1990 357 360
48. G.G. Donders, I. Mertens, G. Bellen, and S. Pelckmans Self-elimination of risk factors for recurrent vaginal candidosis Mycoses 54 2011 39 45
49. J.E. Martin Lopez Candidiasis (vulvovaginal) BMJ Clin Evid 2015
50. A. Ray, S. Ray, A.T. George, and N. Swaminathan Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection Cochrane Database Syst Rev 8 2011 CD008739
51. M.I. Rosa, B.R. Silva, P.S. Pires, and et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis Eur J Obstet Gynecol Reprod Biol 167 2013 132 136
52. A. Cassone Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects BJOG 122 2015 785 794
53. S. Davies, E. Johnson, and D. White How to treat persistent vaginal yeast infection due to species other than Candida albicans Sex Transm Infect 89 2013 165 166
54. S. Fan, X. Liu, C. Wu, L. Xu, and J. Li Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis Mycopathologia 179 2015 95 101
55. S. Guaschino, F. De Seta, A. Sartore, and et al. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis Am J Obstet Gynecol 184 2001 598 602
56. C. Iavazzo, I.D. Gkegkes, I.M. Zarkada, and M.E. Falagas Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence J Womens Health (Larchmt) 20 2011 1245 1255
57. D. Marchaim, L. Lemanek, S. Bheemreddy, K.S. Kaye, and J.D. Sobel Fluconazole-resistant Candida albicans vulvovaginitis Obstet Gynecol 120 2012 1407 1414
58. A. Kalkanci, A.B. Güzel, I.I. Jabban, M. Aydin, M. Ilkit, and S. Kuştimur Candida vaginitis in non-pregnant patients: a study of antifungal susceptibility testing and virulence factors J Obstet Gynaecol 33 2013 378 383
59. C.J. Watson, M. Pirotta, and S.P. Myers Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis-results of a practitioner survey Complement Ther Med 20 2012 218 221
60. M.E. Falagas, G.I. Betsi, and S. Athanasiou Probiotics for prevention of recurrent vulvovaginal candidiasis: a review J Antimicrob Chemother 58 2006 266 272
61. M.B. Liu, S.R. Xu, Y. He, and et al. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis PLoS One 8 2013 e79812
62. X. Zhou, R. Westman, R. Hickey, and et al. Vaginal microbiota of women with frequent vulvovaginal candidiasis Infect Immun 77 2009 4130 4135
63. E.A. Eloe-Fadrosh, and D.A. Rasko The human microbiome: from symbiosis to pathogenesis Annu Rev Med 64 2013 145 163
64. M. Pirotta, J. Gunn, P. Chondros, S. Grover, S. Hurley, and S. Garland The PAV trial: does Lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomized controlled trial [ISRCTN24141277] BMC Fam Pract 5 2004 5